RPAY — what changed in the latest 10-Q
A section-by-section comparison of RPAY's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-04 vs the prior 10-Q · 2025-11-10
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +18 | −45 | ~30 | 43 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 3 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Some risk factors updated | +38 | 0 | ~1 | 0 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-04
Loss per Class A share attributable to the Company - basic and diluted
Total revenue was $80.8 million for the three months ended March 31, 2026, and $77.3 million for the three months ended March 31, 2025, an increase of $3.5 million or 4.5%. This increase was the result of newly signed clients and the growth of our existing clients.
Costs of services were $19.3 million for the three months ended March 31, 2026, and $18.7 million for the three months ended March 31, 2025, an increase of $0.6 million or 3.2%. This increase was the result of newly signed clients and the growth of our existing clients.
Depreciation and amortization expenses were $25.5 million for the three months ended March 31, 2026, and $25.3 million for the three months ended March 31, 2025, an increase of $0.2 million or 0.8%, primarily driven by an increase in software amortization.
Interest expense was $3.8 million for the three months ended March 31, 2026, and $3.1 million for the three months ended March 31, 2025, due to a higher outstanding principal balance under the convertible senior notes and revolving credit facility.
Text removed vs the prior filing · source: 10-Q · 2025-11-10
Weighted-average shares of Class A common stock outstanding - diluted
Total revenue was $77.7 million for the three months ended September 30, 2025, and $79.1 million for the three months ended September 30, 2024, a decrease of $1.4 million or 1.8%. This decrease was due to impacts from previously announced client losses and political media spending in the third quart…
Costs of services were $19.9 million for the three months ended September 30, 2025, and $17.6 million for the three months ended September 30, 2024, an increase of $2.4 million or 13.6%. This increase was the result of newly signed clients and the growth of our existing clients, partially offset fro…
Depreciation and amortization expenses were $25.6 million for the three months ended September 30, 2025, and $25.5 million for the three months ended September 30, 2024, an increase of $0.1 million or 0.4%, primarily driven by an increase in amortization in software.
Interest expense was $3.1 million for the three months ended September 30, 2025, and $2.9 million for the three months ended September 30, 2024, due to a higher outstanding principal balance under the convertible senior notes.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-04
Delaware law, our governing documents and our stockholder rights plan contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
Our certificate of incorporation, bylaws and Delaware General Corporation Law (“DGCL”) contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our board of directors and therefore depress the trading price of our Class A…
the ability of our board of directors to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownersh…
the right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;
a prohibition on stockholder action by written consent (except in limited circumstances), which forces stockholder action to be taken at an annual or special meeting of stockholders and could delay the ability of stockholders to force consideration of a stockholder proposal or to take action, includ…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice